30UC | pdb_000030uc

Complex of transglutaminase 2 and the 45 kDa domain of fibronectin


Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 2.80 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

wwPDB Validation 3D Report Full Report

Validation slider image for 30UC

This is version 1.1 of the entry. See complete history

Literature

Cryo-EM structure of the complex between transglutaminase 2 and the 45 kDa domain of fibronectin.

Heggelund, J.E.Ali-Ahmad, A.Johannesen, M.K.Sekulic, N.Sollid, L.M.

(2026) J Biol Chem : 113326-113326

  • DOI: https://doi.org/10.1016/j.jbc.2026.113326
  • Primary Citation Related Structures: 
    30UC

  • PubMed Abstract: 

    Fibronectin (FN) and transglutaminase 2 (TG2) engage in a high-affinity interaction. This interaction affects anchoring, migration and survival of cells, and high cellular expression of TG2 is associated with metastasis potential of cancers. Previous work has mapped the interaction to involve the N-terminal part of TG2 and an N-terminally located 45 kDa domain of FN (FN45). In particular, the I 8 module of FN45 is reported to be necessary and sufficient for TG2 binding. Here, we present the cryo-EM structure of a complex between human TG2 and FN45 at 2.8 Å resolution. In the structure, the distal region of the TG2 N-terminal domain binds the FN45 I 8 module, whereas the proximal N-terminal region and adjacent catalytic core segment bind the FN45 I 7 module and, to a lesser extent, the FN45 II 2 module. The FN45 I 7 and FN45 I 8 modules have about equal buried surface areas in their interaction with TG2. A glycine residue at position 127 of TG2 is crucial for interaction with Trp553 of the FN45 I 8 module. Mutation of this residue to isoleucine, which is carried by transglutaminase 3 that does not bind FN45, abrogates the binding of FN45 to TG2. This finding suggests that the interaction of the FN45 I 7 module with TG2 is contingent on the FN45 I 8 module making an interaction with TG2. Further, this finding highlights the region surrounding residue 127 of TG2 as a promising target for structure-based design of anticancer drugs aimed at disrupting the TG2-FN interaction.


  • Organizational Affiliation
    • Norwegian Coeliac Disease Research Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital - Rikshospitalet, Oslo, Norway. Electronic address: j.e.heggelund@medisin.uio.no.

Macromolecule Content 

  • Total Structure Weight: 115.7 kDa 
  • Atom Count: 6,520 
  • Modeled Residue Count: 810 
  • Deposited Residue Count: 1,014 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Protein-glutamine gamma-glutamyltransferase 2712Homo sapiensMutation(s): 0 
Gene Names: TGM2
EC: 2.3.2.13 (PDB Primary Data), 3.4 (PDB Primary Data), 3.5.1.44 (PDB Primary Data), 2.3.1 (PDB Primary Data)
UniProt & NIH Common Fund Data Resources
Find proteins for P21980 (Homo sapiens)
Explore P21980 
Go to UniProtKB:  P21980
GTEx:  ENSG00000198959 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP21980
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
Fibronectin302Homo sapiensMutation(s): 0 
UniProt & NIH Common Fund Data Resources
Find proteins for P02751 (Homo sapiens)
Explore P02751 
Go to UniProtKB:  P02751
GTEx:  ENSG00000115414 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP02751
Glycosylation
Glycosylation Sites: 2Go to GlyGen: P02751-15
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 2.80 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 
EM Software:
TaskSoftware PackageVersion
RECONSTRUCTIONcryoSPARC
MODEL REFINEMENTPHENIX2.0_5936

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Other privateDenmarkLF-OC-23-001291
Research Council of NorwayNorway295844

Revision History  (Full details and data files)

  • Version 1.0: 2026-07-22
    Type: Initial release
  • Version 1.1: 2026-07-29
    Changes: Data collection, Database references